ClinConnect ClinConnect Logo
Search / Trial NCT06830785

Effects of RAS in Stroke

Launched by SHU-MEI WANG · Feb 11, 2025

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating whether using rhythmic sounds can help improve movement and quality of life for patients who have had a stroke. Specifically, researchers want to know if listening to music or beats while practicing movements can make it easier and faster for stroke patients to perform daily activities, recover movement in their affected arm, and enhance their overall well-being. To find this out, they will compare two groups: one that receives movement training with rhythmic sounds and another that trains without these sounds.

To participate in the study, individuals must be between 65 and 74 years old and have had a stroke at least six months ago. They should have some ability to move their affected arm and be able to follow instructions. Participants will be involved in 24 training sessions lasting 40 minutes each, three times a week. They will also complete movement tests and questionnaires before and after the program to track their progress. The trial is not yet recruiting participants, but it aims to help stroke survivors regain movement and improve their daily lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • (1) Diagnosed with either ischaemic or hemorrhagic stroke, and a first-time occurrence;
  • (2) A unilateral stroke;
  • (3) The onset occurred six months or more prior to the experiment, indicating a chronic stage of stroke;
  • (4) The affected upper limb's proximal and distal joints are between Brunnstrom stages four to six, ensuring that the affected limb can execute the upper-limb functional movement training of this study;
  • (5) The affected upper limb's Modified Ashworth Scale score is ≤ 2, indicating no significant muscle stiffness (spasticity) in the affected limb;
  • (6) A Montreal Cognitive Assessment score of ≥ 24, ensuring comprehension of the instructions given during this study;
  • and (7) when we clap hands next to the affected ear of the participant who closes eyes, the participant is able to indicate the sound's source either verbally or through gestures, indicating no complete hearing loss in the affected ear and the ability to receive rhythmic auditory stimulation.
  • Exclusion Criteria:
  • (1) Neurological diseases or medical conditions that affect upper-limb movements or hearing;
  • (2) Being participating in other experimental studies related to drug treatment or upper-limb movement therapy.

About Shu Mei Wang

Shu-Mei Wang is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and innovation. With a focus on enhancing patient outcomes, she leads initiatives that prioritize ethical standards and regulatory compliance throughout the clinical trial process. Leveraging her extensive expertise in trial design and management, Shu-Mei fosters collaborative partnerships with healthcare professionals and research institutions to drive meaningful advancements in therapeutic development. Her strategic approach emphasizes patient safety, data integrity, and the efficient execution of clinical studies, ultimately contributing to the progression of healthcare solutions.

Locations

Taipei, , Taiwan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported